$Clearone(CLRO.US) surged +166% in a single day, briefly spiking over +200% during trading. The catalyst was an SEC filing—share issuance related to the merger with Cortigent received shareholder approval, and it continued to rise nearly 5% after hours.

Its original professional audio-video conferencing assets have been sold to Biamp, while the remaining shell is pivoting toward neurotechnology. With a market cap of just over $10 million and inherently low float, the increased certainty of the merger progression removed price resistance.

This rally, driven by shell resource restructuring, prices in the imaginative potential of the new business post-merger, not current financial statements. The true test lies in the first quarterly report after the merger completes—the pipeline progress and cash burn rate of Cortigent will be far more significant than the approval announcement itself.